Related Experiment Videos
Costs of schizophrenia
1London School of Economics.
Summary
Schizophrenia incurs significant costs, but evidence shows cost-effective treatments and community care can reduce this burden. Investing in interventions improves patient outcomes and societal impact.
Area of Science:
- Health Economics
- Psychiatry
- Public Health
Background:
- Schizophrenia is a prevalent and impactful illness affecting healthcare, social services, patients, and families.
- The economic and societal burden of schizophrenia is substantial and widespread.
Purpose of the Study:
- To review UK evidence on the economic costs of schizophrenia.
- To evaluate the cost-effectiveness of various treatment options and care models for schizophrenia.
Main Methods:
- Systematic review of existing UK evidence on schizophrenia costs.
- Analysis of cost-effectiveness data for treatments and care arrangements.
Main Results:
- The estimated annual cost of schizophrenia in England is £2.6 billion, excluding some indirect impacts.
- Direct costs to the NHS, local authorities, charities, and the justice system constitute over half of the total identified costs.
- Evidence supports the cost-effectiveness of community care, antipsychotic medications, and psychological interventions.
Conclusions:
- Schizophrenia presents considerable economic challenges.
- Effective treatments and care strategies exist to mitigate the financial and societal burden of schizophrenia.
- Implementing cost-effective interventions can maintain or enhance treatment efficacy while reducing overall costs.